| Chemopreventive and therapeutic effects of curcumin A Duvoix, R Blasius, S Delhalle, M Schnekenburger, F Morceau, E Henry, ... Cancer letters 223 (2), 181-190, 2005 | 1173 | 2005 |
| Molecular and therapeutic potential and toxicity of valproic acid S Chateauvieux, F Morceau, M Dicato, M Diederich BioMed Research International 2010 (1), 479364, 2010 | 634 | 2010 |
| Erythropoietin, erythropoiesis and beyond S Chateauvieux, C Grigorakaki, F Morceau, M Dicato, M Diederich Biochemical pharmacology 82 (10), 1291-1303, 2011 | 235 | 2011 |
| Pro‐inflammatory cytokine‐mediated anemia: Regarding molecular mechanisms of erythropoiesis F Morceau, M Dicato, M Diederich Mediators of inflammation 2009 (1), 405016, 2009 | 197 | 2009 |
| Induction of apoptosis by curcumin: mediation by glutathione S-transferase P1-1 inhibition A Duvoix, F Morceau, S Delhalle, M Schmitz, M Schnekenburger, ... Biochemical pharmacology 66 (8), 1475-1483, 2003 | 186 | 2003 |
| An introduction to the molecular mechanisms of apoptosis S Delhalle, A Duvoix, M Schnekenburger, F Morceau, M Dicato, ... Annals of the New York Academy of Sciences 1010 (1), 1-8, 2003 | 118 | 2003 |
| Effect of chemopreventive agents on glutathione S-transferase P1-1 gene expression mechanisms via activating protein 1 and nuclear factor kappaB inhibition A Duvoix, S Delhalle, R Blasius, M Schnekenburger, F Morceau, ... Biochemical pharmacology 68 (6), 1101-1111, 2004 | 107 | 2004 |
| Inhibition of TNFα-induced activation of nuclear factor κB by kava (Piper methysticum) derivatives F Folmer, R Blasius, F Morceau, J Tabudravu, M Dicato, M Jaspars, ... Biochemical pharmacology 71 (8), 1206-1218, 2006 | 105 | 2006 |
| Heteronemin, a spongean sesterterpene, inhibits TNFα-induced NF-κB activation through proteasome inhibition and induces apoptotic cell death M Schumacher, C Cerella, S Eifes, S Chateauvieux, F Morceau, ... Biochemical Pharmacology 79 (4), 610-622, 2010 | 101 | 2010 |
| UNBS1450, a steroid cardiac glycoside inducing apoptotic cell death in human leukemia cells T Juncker, C Cerella, MH Teiten, F Morceau, M Schumacher, J Ghelfi, ... Biochemical pharmacology 81 (1), 13-23, 2011 | 98 | 2011 |
| Natural and synthetic flavonoids: structure–activity relationship and chemotherapeutic potential for the treatment of leukemia JC Menezes, B Orlikova, F Morceau, M Diederich Critical reviews in food science and nutrition 56 (sup1), S4-S28, 2016 | 91 | 2016 |
| Linking anemia to inflammation and cancer: the crucial role of TNFα I Buck, F Morceau, C Grigorakaki, M Dicato, M Diederich Biochemical pharmacology 77 (10), 1572-1579, 2009 | 89 | 2009 |
| GATA‐1: Friends, brothers, and coworkers F Morceau, M Schnekenburger, M Dicato, M Diederich Annals of the New York Academy of Sciences 1030 (1), 537-554, 2004 | 86 | 2004 |
| Tumor necrosis factor α inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 … I Buck, F Morceau, S Cristofanon, C Heintz, S Chateauvieux, S Reuter, ... biochemical pharmacology 76 (10), 1229-1239, 2008 | 85 | 2008 |
| Long and short non-coding RNAs as regulators of hematopoietic differentiation F Morceau, S Chateauvieux, A Gaigneaux, M Dicato, M Diederich International journal of molecular sciences 14 (7), 14744-14770, 2013 | 80 | 2013 |
| Sphingolipid-mediated inflammatory signaling leading to autophagy inhibition converts erythropoiesis to myelopoiesis in human hematopoietic stem/progenitor cells M Orsini, S Chateauvieux, J Rhim, A Gaigneaux, D Cheillan, C Christov, ... Cell Death & Differentiation 26 (9), 1796-1812, 2019 | 76 | 2019 |
| Tumor necrosis factor alpha-mediated inhibition of erythropoiesis involves GATA-1/GATA-2 balance impairment and PU. 1 over-expression C Grigorakaki, F Morceau, S Chateauvieux, M Dicato, M Diederich Biochemical pharmacology 82 (2), 156-166, 2011 | 67 | 2011 |
| Regulation of glutathione S-transferase P1-1 gene expression by NF-kappaB in tumor necrosis factor alpha-treated K562 leukemia cells F Morceau, A Duvoix, S Delhalle, M Schnekenburger, M Dicato, ... Biochemical pharmacology 67 (7), 1227-1238, 2004 | 63 | 2004 |
| Curcumin‐induced cell death in two leukemia cell lines: K562 and Jurkat A Duvoix, F Morceau, M Schnekenburger, S Delhalle, MM GALTEAU, ... Annals of the New York Academy of Sciences 1010 (1), 389-392, 2003 | 63 | 2003 |
| Anthracyclines as tumor cell differentiating agents: effects on the regulation of erythroid gene expression P Jeannesson, R Lahlil, B Chenais, L Devy, R Gillet, A Aries, F Morceau, ... Leukemia & lymphoma 26 (5-6), 575-587, 1997 | 51 | 1997 |
Marc DiederichProfessor, College of Pharmacy, Seoul National University, South Korea; LBMCC, Luxembourg在 snu.ac.kr 的电子邮件经过验证
